STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS. Int. Res. J. Pharm. [Internet]. 2018 Aug. 30 [cited 2026 May 31];9(8):125-8. Available from: https://irjponline.org/index.php/irjp/article/view/3224